---
title: "Castle Biosciences CEO Derek J. Maetzold Reports Sale of Common Shares"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/273423499.md"
datetime: "2026-01-22T21:16:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273423499.md)
  - [en](https://longbridge.com/en/news/273423499.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273423499.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/273423499.md) | [English](https://longbridge.com/en/news/273423499.md)


# Castle Biosciences CEO Derek J. Maetzold Reports Sale of Common Shares

Derek J. Maetzold, President and Chief Executive Officer of Castle Biosciences Inc., reported a disposal of common shares of the company, according to a recent SEC filing. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Castle Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-003089), on January 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### 相關股票

- [iShares Genomics Immunology and Healthcare ETF (IDNA.US)](https://longbridge.com/zh-HK/quote/IDNA.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-HK/quote/PBE.US.md)
- [iShares US Healthcare Providers (IHF.US)](https://longbridge.com/zh-HK/quote/IHF.US.md)
- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-HK/quote/FBT.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-HK/quote/BBH.US.md)
- [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-HK/quote/SBIO.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-HK/quote/IBB.US.md)
- [iShares US Medical Devices (IHI.US)](https://longbridge.com/zh-HK/quote/IHI.US.md)
- [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-HK/quote/XBI.US.md)
- [Castle Biosciences (CSTL.US)](https://longbridge.com/zh-HK/quote/CSTL.US.md)
- [Health Care Select Sector SPDR (XLV.US)](https://longbridge.com/zh-HK/quote/XLV.US.md)
- [Ark Genomic Revolution ETF (ARKG.US)](https://longbridge.com/zh-HK/quote/ARKG.US.md)
- [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-HK/quote/BIB.US.md)

## 相關資訊與研究

- [BUZZ-Tempus AI rises after study shows AI-driven alerts improve heart valve treatment](https://longbridge.com/zh-HK/news/281390073.md)
- [Io Biotech Inc - Files Voluntary Chapter 7 Bankruptcy Petition On March 31, 2026 - SEC Filing](https://longbridge.com/zh-HK/news/281187506.md)
- [ResMed CFO Brett Sandercock disposes of common shares worth $0.2 million](https://longbridge.com/zh-HK/news/281632265.md)
- [Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update](https://longbridge.com/zh-HK/news/281525623.md)
- [Allworth Financial LP Reduces Holdings in Biodesix, Inc. $BDSX](https://longbridge.com/zh-HK/news/281318320.md)